Supply Chain Management of Sanofi Aventis - 5271 Words

[pic] Introduction 2 1.1 Broad Objective 2 1.2 Specific Objectives 2 1.3 Scope 2 1.4 Methodology 3 1.5 Limitation 3 VALUES: 4 MISSION OF SUPPLY CHAIN 5 STRCTURE OF THE SUPPLY CHAIN 6 DISTRIBUTION FACILITIES: 9 KEY FIGURES DISTRIBUTION 9 MAPPING OF PRODUCT DISTRIBUTION 10 DISTRIBUTION PROCESS FLOW CHART 11 Definition-Target: 12 Addresses: 12 Target: 12 Field of application: 13 General Rules of Finished Goods Stock Cover: 13 Stock Policy / Product Life: 13 Standard Rules of Finished Products Stocks Cover: 14 Optimized practice of stocks targeting: 16 RAG/VMI products Stocks Cover Target (on hand, available to sale): 16 RAG/VMI Products Stocks Cover Targets: 17 Monitoring Rules-†¦show more content†¦| |Performance |The key to future | 9 10 MISSION OF SUPPLY CHAIN Develop the best Service to Customers by managing: ââ€" ª With a single teamShow MoreRelatedThe Impacts of Mncs in the Economy of Bangladesh14643 Words   |  59 PagesAmong them Standard Chartered bank (BD) ltd, British American Tobacco (BAT) Bangladesh ltd. is most renown. BAT came in East Pakistan (now Bangladesh) in1945.Standarad Chartered Bank came in Bangladesh in 1948.Another business conglomerate Aventis (now Sanofi Aventis ) launched in Bangladesh in 1973.so coming of a lot of foreign companies in Bangladesh still going on .Ours have a large population and low cost labor force as well. As a result MNCs are enjoying a smooth pave to come in Bangladesh. As farRead MoreThe Impact of a Crm System on a Pharmaceutical Organisation Essay2854 Words   |  12 Pages As a result sales strategies must evolve from quantity to quality through targeted messaging. (Hall, 2004) In December 2006, the marketing VP for Sanofi-Aventis stated: â€Å"We are so far behind other industries but the good news is that CRM can change marketing practices.† With the above indications of the importance of Customer Relationship Management (CRM) in mind, I am going to discuss the implementation of a CRM system in a pharmaceutical organisation. Definitions of CRM and CRM systems are wideRead MoreMergers and Acquisitions in the Pharmaceutical Sector Since the Last 10years to Cope with the Mutations of This Sector.7658 Words   |  31 Pagesanalysis of our training: the pharmaceutical industry. This area seems worthy review because this sector is under-research every year in many countries, for example there are research by Joel Lexchin,  associate professor School of Health Policy and Management, York University, Toronto (  Drugs of Choice: A Formulary for General Practice),  Lisa A Bero,  professor, Department of Clinical Pharmacy and Institute for Health Policy Studies, University of California at San Francisco(Financial Ties and ConflictsRead MorePfizer to Acquire Protalix10020 Words   |  41 Pagesfor the Pharmaceutical Industry 25 Appendix 4 - Pfizers PEST Analysis 27 Appendix 5 - Level of Competition Between the Acquirers amp; the Uniqueness of the Acquired Company 31 Appendix 6 - Acquisition Motives 33 Appendix 7 - Protalix Management and Board of Directors 35 Appendix 8 - Technology Adoption Lifecycle 36 Appendix 9 - Pfizers SWOT Analysis 36 Appendix 10 - Protalixs Financials 38 Appendix 11 - About the Valuation Methods 40 Appendix 12 - List of Companies andRead MoreEli Lilly in India3134 Words   |  13 PagesGilbert Eli Lilly in India: Rethinking the Joint Venture Strategy Executive Summary Eli Lilly and Company is a pharmaceutical company, founded in 1876, that integrates many departments and supply-chain management.    The company in itself discovers, develops, manufactures, and sells a broad line of human health and agricultural products (Lilly.com). Eli Lilly had grown to become one of the leading pharmaceutical companies in the United States, andRead MoreGlobal Pharmaceutical Industry Analysis7049 Words   |  29 PagesSwitzerland 53,324 7,125 11,053 138,000 2 Pfizer USA 48,371 7,599 19,337 122,200 3 Bayer Germany 44,200 1,791 6,450 106,200 4 GlaxoSmithKline United Kingdom 42,813 6,373 10,135 106,000 5 Johnson and Johnson USA 37,020 5,349 7,202 102,695 6 Sanofi-Aventis France 35,645 5,565 5,033 100,735 7 Hoffmann–La Roche Switzerland 33,547 5,258 7,318 100,289 8 AstraZeneca UK/Sweden 26,475 3,902 6,063 50,000+ 9 Merck Co. USA 22,636 4,783 4,434 74,372 10 Abbott Laboratories USA 22,476 2,255 1,717Read MoreProblems Facing the Pharmaceutical Industry and Approaches to Ensure Long Term Viability14741 Words   |  59 PagesExpected Global NCE Launches for 2009 Product Delays and Non-Approvals High Level Breakdown of RD Costs Estimates of RD Costs Generic Sales Projection Through 2012 Healthcare Spending Trends E7 Health Demographics E7 Therapy Classes Portfolio Management Objectives Examples of SIPOC Page 5 6 7 8 9 11 13 14 29 45 vi TABLE OF CONTENTS Page ABSTRACT ACKNOWLEDGEMENTS LIST OF TABLES LIST OF FIGURES CHAPTER 1 2 3 4 5 6 7 8 9 10 Introduction Pharmaceutical Industry Response Interview SummaryRead MoreGsk Marketing Planning4419 Words   |  18 Pagesmarket share and high market growth rate along with a good cash flow. This puts GSK under â€Å"star† category in the Boston matrix. GSK has a product portfolio with a significant cash flow position this in turn has spurred on a meaningful gearing by GSK management. This puts the company firmly in a star performing position. With asset consolidation of $23.5bn USD over three years, the company is likely to attain double-digit earnings growth, with mid-digit growth in 2012 impacted by generic competition. Read MoreMergers Acquisitions in Pharma Industry21425 Words   |  86 PagesIndia GSK’s success in India has been based on several key success factors: Local Strategy within Global Framework Within the guidelines of ethical business and medical practices, GSK Plc has given a fair amount of autonomy to the local management in running the India business. The company’s country specific strategy, perseverance and willingness to work with the policy makers have contributed greatly to its success in India. In-licensing To augment its portfolio and to counter theRead MoreLOreal - Business Policy and Strategy8843 Words   |  36 Pagesthis Committee is to ensure that the General Management is provided with information enabling it to identify and manage the economic, financial and legal risks faced by the group both inside and outside France in its routine and exceptional operations. The Management and Remuneration Committee (3 members)This Committee assists, in complete independence, the Chairman and the Board in their review of succession plans for the groups senior management positions. It reviews the composition of the